Related references
Note: Only part of the references are listed.DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
Matias Iglicki et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Intravitreal dexamethasone implant Ozurdex® in naive and refractory patients with different subtypes of diabetic macular edema
Veronica Castro-Navarro et al.
BMC OPHTHALMOLOGY (2019)
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Catharina Busch et al.
ACTA DIABETOLOGICA (2018)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
Jin-Woo Kwon et al.
PLOS ONE (2018)
Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies
Laurent Kodjikian et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Diabetic macular oedema: evidence-based treatment recommendations for Asian countries
Gemmy C. M. Cheung et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGICA (2017)
Novel therapeutic targets in diabetic macular edema: Beyond VEGF
Elizabeth A. Urias et al.
VISION RESEARCH (2017)
Diabetic macular oedema
Gavin S. Tan et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Efficacy of the Intravitreal Sustained-Release Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-Vascular Endothelial Growth Factor Therapy: Meta-Analysis and Clinical Implications
Zainab Khan et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial
Peter A. Campochiaro et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Early and Long-Term Responses to Anti Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Victor H. Gonzalez et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)
Samantha Fraser-Bell et al.
OPHTHALMOLOGY (2016)
PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA
Sanket U. Shah et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2016)
REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT
Ariane Malclès et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Sebastien Guigou et al.
OPHTHALMOLOGICA (2015)
Dexamethasone Implants in Patients with Naive or Refractory Diffuse Diabetic Macular Edema
Jose Juan Escobar-Barranco et al.
OPHTHALMOLOGICA (2015)
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
Albert J. Augustin et al.
BMC OPHTHALMOLOGY (2015)
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
Pravin U. Dugel et al.
CLINICAL OPHTHALMOLOGY (2015)
A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
Farzin Forooghian et al.
ACTA OPHTHALMOLOGICA (2011)
Effect of Intravitreal Bevacizumab Injection on Aqueous Humor Cytokine Levels in Clinically Significant Macular Edema
Mi In Roh et al.
OPHTHALMOLOGY (2009)
Share Paper
